Haleon PLC (GB:HLN) has released an update.
Haleon PLC has announced the purchase and subsequent cancellation of 462,500 of its ordinary shares at prices ranging between 386.9 to 390.7 pence per share, as part of its share buyback program initiated on August 1, 2024. Post-transaction, Haleon’s total registered share capital consists of over 9 billion shares, with the detailed transaction information available for shareholders on the company’s website and the London Stock Exchange. Haleon, known for trusted brands in consumer health like Advil and Sensodyne, continues to reinforce its market presence.
For further insights into GB:HLN stock, check out TipRanks’ Stock Analysis page.
